Objectives: Exercise induces changes in haemostatic parameters and core body temperature 2 (CBT). We aimed to assess whether exercise-induced elevations in CBT induce pro-3 thrombotic changes in a dose-dependent manner. 4
Introduction

1
Strenuous exercise induces a hypercoagulable state, hallmarked by an increased factor VIII 2 concentration and a subsequently increased (in vitro) thrombin generation [1] [2] [3] . The increased 3 thrombin enables fibrin formation, which stabilizes the platelet plug 4 . Simultaneous to these 4 prothrombotic changes, increased levels of tissue plasminogen activator and reduced levels 5 of plasminogen activator inhibitor hallmark increased fibrinolysis 1 3 4 . In this manner, the 6 prothrombotic effects of exercise are offset by increased fibrinolysis, which prevents the 7 formation of excess blood clots. Whilst the magnitude of these haemostatic changes are 8 generally well balanced during general aerobic exercise, they are associated with an 9 increased risk of cardiovascular complications such as acute coronary syndrome in individuals 10 with previous cardiovascular disease 5 .
12
In addition to prothrombotic changes, exercise also leads to an increase in core body 13 temperature (CBT) 6 7 . Whilst this exercise-induced CBT increase is a normal result of 14 metabolic heat production 8 , excessive increases in CBT to values above 40°C can potentially 15 result in heatstroke 6 9 10 . Heatstroke is characterized by neurological symptoms (delirium, 16 coma) and a derailed haemostatic response that results in a disease state similar to diffuse 17 intravascular coagulation [9] [10] [11] . Potential consequences of heatstroke are multi-organ failure, in 18 part due to thrombotic complications, and may result in death 9 . Hence, strong CBT rises during 19 exercise bear the risk of developing potential serious thrombotic complications. Conversely, 20 hypothermia (a CBT <35°C) has been shown to negatively impact on haemostatic activity, 21 resulting in an increased bleeding diathesis 12 13 . These observations suggest that CBT directly 22 impacts on the activity of the haemostatic system, and the procoagulant responses during 23 exercise could thus theoretically be partly caused by an increased CBT. However, whether an 24 increased CBT during exercise actually induces prothrombotic changes in a dose-dependent 25 manner is currently unknown. 26
27
.
13
Subjects ingested an individually calibrated telemetric temperature pill at least five hours (8 14 a.m.) before the race (start 1 p.m.) to prevent interaction of the CBT measurements with fluid 15 ingestion during testing 18 . CBT was measured using a portable telemetry system (CorTemp™ 16 system, HQ Inc., Palmetto, USA), which has been demonstrated to safely and reliably 17 measure CBT 19 20 . The average of three consecutive measurements for each time point was 18 used for further analyses. 19
Based on finish CBT, subjects were classified as low-(CBT <39) moderate-(39≥ finish CBT 20 <40) or high-responders (CBT ≥40). The exercise-induced increase in CBT (ΔCBT) was 21 calculated by subtracting baseline CBT from finish CBT. Again, three subgroups were created 22 to classify low-(ΔCBT < 1.5) moderate-(1.5≥ ΔCBT <2.5) and high-responders (ΔCBT ≥2.5). 23 
24
Venous blood samples were collected from an anticubital vein in CTAD (sodium citrate 25 theophylline, adenosine dypyridamol) buffered collection tubes in our on-site laboratory. 26
Samples were centrifuged at 4200 rpm for 15 minutes, after which the plasma was 27 immediately transferred into new uncoated Eppendorf tubes which were subsequently snap 28 frozen in liquid nitrogen and stored at -80°C until further analysis. Thrombin and plasmin 1 generation were simultaneously measured using the 'Nijmegen Haemostasis Assay'
21
. This 2 assay allows simultaneous measurement of in vitro thrombin and plasmin generation in the 3 same blood specimen in a single well (Supplemental Figure 1) . Lag time thrombin generation 4 describes the lag time between activation of the coagulation cascade and the time at which 5 the initiation of thrombin generation is measured. Time to thrombin peak refers to the time 6 between activation of the coagulation cascade and reaching the peak thrombin generation 7 value. Thrombin peak height refers to the maximal thrombin generation rate. The area under 8 the curve reflects the total thrombin potential (AUCthrombin). Plasmin peak time refers to the time 9 between activation of the coagulation cascade and the time at which the plasmin peak is 10 reached. Plasmin peak height refers to the maximal plasmin generation rate. Fibrin lysis time 11 refers to the time between the start of plasmin generation and the moment at which plasmin 12 peak height is attained. In all instances, each plasma sample was analysed in duplicate and 13 the average of each duplicate was used for further analysis. The inter-assay variation of 14 thrombin generation parameters varies from 5.9% (AUCthrombin) to 25% (lag time thrombin 15 generation). The inter-assay variation of plasmin generation parameters varies from 10% 16 (plasmin peak height) to 14% (plasmin potential). 17
For aim 2, we re-analysed the plasma samples at an assay temperature nearest to the 18 subject's CBT at baseline and finish in a subgroup of n=25. For example, if a subject had a 19 baseline CBT of 37.4°C, the assay was performed at 37°C, whereas in case of a baseline 20 CBT of ≥37.5°C and ≤38.4°C the assay was performed at 38°C. Likewise, a finish CBT of 21 39.4°C was analysed at an assay temperature of 39°C and finish CBT ≥39.5°C at 40°C. Within 22 this subgroup we also measured additional haemostatic parameters, in order to quantify the 23 in vivo haemostatic activity. Plasma prothrombin fragment 1+2 was measured to assess the 24 in vivo thrombin generation using an ezyme-linked immunosorbent assay (ELISA; Enzygnost 25 F1+2, Behring Diagnostics GmbH, Frankfurt, Germany), while plasma D-dimer levels were 26 measured to quantify the in vivo fibrinolysis activity using an ELISA (Zymutest D-dimer, 27
Hyphen BioMed, Neuville-sur-Oise, France). Furthermore, we determined the isolated effect 28 of the assay temperature on haemostasis parameters by performing the analyses at 37°C, 1 38°C, 39°C and 40°C in the subgroup of n=25. reported as mean ± standard deviation unless otherwise indicated. All haemostasis data were 6 visually inspected for normality distribution. In case of a non-Gaussian distribution, log-7 transformation was performed and data were re-inspected. If a normal distribution could not 8 be attained, non-parametric analyses were performed. The impact of exercise on changes in 9 haemostatic parameters was assessed using a paired Student's T-Test. To test the hypothesis 10 that a higher finish CBT would aggravate the exercise-induced haemostatic responses two-11 way repeated measurements analysis of variance (Gaussian distributed data) and Kruskal-12
Wallis or Friedman test (non-Gaussian distributed data) were used. The relationship between 13 finish CBT and post-exercise haemostasis parameters was calculated using a Pearson 14 (Gaussian distributed data) or Spearman's rank correlations (non-Gaussian distributed data). 15
16
Results
17
All subjects completed the race in cool environmental conditions (Wet bulb globe temperature 18 12.5°C, Dry-Bulb temperature 10.5°C, relative humidity 87%, wind speed 3.4 -5.4 m/s) at an 19 average running speed of 12.1±1.8 km/h. The average body weight loss during the race was 20 -1.4±0.6% of total body weight, and 18% of all subjects classified as dehydrated. Post-21 exercise, lag time in thrombin generation (baseline 4.5±1.1 versus finish 3.8±0.7 min; p<0.001) 22
and time to thrombin peak (9.0±1.4 vs. 8.0±0.9 min; p<0.001) were significantly shortened, 23 and high-CBT responders compared to low-CBT responders. Similarly, the magnitude of 9
ΔCBT did not interact with changes in haemostatic parameters (Supplemental Table 1 ). Lastly, 10 neither finish-CBT nor ΔCBT correlated significantly with post-exercise haemostasis 11 parameters, body weight loss or running speed (Supplemental Table 2 ). 12
13
Synchronisation of the haemostatic assay temperature to actual baseline and finish CBT 14 resulted in a significant decrease of lag time thrombin generation, time to thrombin peak, 15 thrombin peak height and AUCthrombin between baseline and finish ( Figure 1A-D respectively) . 16
Plasmin peak time synchronized to actual CBT and plasmin peak height decreased 17 significantly between baseline and finish ( Figure 1E + F) , whilst fibrin lysis time did not change 18 significantly ( Figure 1G ). Interestingly, a high finish CBT resulted in a prolonged fibrin lysis 19 time, which was in contrast with subjects that reported a moderate and low finish CBT and 20 demonstrated a shorter fibrin lysis time (Table 2 ). In addition, fragment 1+2 increased from 21 analyses of n=25 (Supplemental Table 3 ). 26
Discussion
1
The purpose of this study was to investigate whether the exercise-induced CBT-rise causes 2 prothrombotic changes in a dose-dependent manner, and whether correcting the temperature 3 at which the haemostasis assay is performed to approximate the subjects' actual CBT alters 4 the haemostasis outcomes. Our study demonstrates that thrombin generation peaked 5 significantly earlier after the race compared to baseline and that plasmin peak height was 6 significantly lower after finishing. However, changes in haemostatic parameters were not 7 related to finish CBT or ΔCBT. The novelty of our findings lies in the adjustment of the assay 8 temperatures to approximate the subjects' CBT. Correcting the assay temperature resulted in 9 more pronounced changes of time to thrombin peak and AUCthrombin, and resulted in the 10 additional identification of a significantly shortened lag time thrombin generation, decreased 11 thrombin peak height and a significant impact of finish CBT on fibrin lysis time. These results 12
suggest that increases in CBT may partially contribute to the exercise-induced haemostatic 13 activation, but that (short lasting) exposure to CBTs up to 41.2°C does not result in clinical 14 symptoms of increased coagulation. Hence, prolonged exposure or a higher CBT is needed 15 to induce excessive coagulation that is typically observed in athletes diagnosed with 16 heatstroke. Most importantly, our results demonstrate that synchronization of the temperature 17 at which haemostasis assays are performed significantly influences the results. In situations 18
where CBT is outside of normal (36.0 -37.5°C) range, it is essential to adjust the assay 19 temperature to obtain the most accurate results. 20
21
Participants of our study demonstrated a large (1.8±0.9°C) and significant increase in CBT 22 after running a 15 km road race, with an average finish CBT of 39.4±0.8°C. These 23 thermoregulatory responses are in agreement with a previous study 7 . Our subjects were well 24 trained (3.6±2.1 hrs/week) and were thus well accustomed to the elevated CBT caused by the 25 exercise itself. We also observed a significant activation of the haemostatic balance, as 26 expressed by a faster thrombin generation and an attenuated plasmin response. These 27 10 findings confirm the prothrombotic effects of exercise that were reported previously 4 5 22
. Since 1 prolonged endurance training has previously been shown to attenuate the prothrombotic 2 effects of exercise 23 , our findings might have been more pronounced in an untrained control 3 group. Independent of training status, the combination of a large inter-individual variation in 4 CBT with a significant haemostatic activation allows us to explore the potential relationship 5 between these exercise-induced phenomena. 6 7 Haemostatic responses were largely comparable between low, moderate and high responders 8 of finish CBT. Although the AUCthrombin was significantly higher in moderate-and high-9 responders compared to low-responders, the other exercise-induced haemostatic changes 10 did not differ across finish-CBT groups. In contrast to our hypothesis, these data suggest that 11 the exercise-induced pro-thrombotic changes do not depend on finish CBT. The observation 12 of a massive haemostatic activation in patients with heatstroke suggests that excessive 13 thrombotic responses may only occur above a certain CBT threshold or after prolonged 14 exposure to a high CBT 24 25 . Hence, the peak finish CBT that was reported in our study 15 (41.2°C) was apparently either too low to induce substantial activation of the coagulation 16 cascade, or too short lasting to induce substantial changes. Data from several animal studies 17 reinforced this hypothesis and showed that prolonged (2.5 -3 hours) passive heating with a 18 CBT >42°C was needed to induce excessive activation of the haemostatic response 11 26 27 . 19
Indeed, the finish CBTs that were observed in our subjects did not result in a derailed 20 haemostatic response nor in clinical symptoms. This was supported by the statistically 21 significant, though clinically irrelevant, increase in plasma prothrombin fragment 1+2 and d-22 dimer levels in absence of a correlation of these parameters with finish CBT. Therefore, 23 physical exercise typically performed by the general population does not necessarily result in 24 a derailment of blood haemostasis. 25 26 Importantly, the absence of an interaction between CBT and haemostasis may relate to the 27 fact that analyses were performed at 37°C instead of the actual CBT at the time of blood 28 collection. When synchronizing the assay temperature to the individual's baseline and finish 1 CBT, we observed additional and stronger baseline-to-finish changes in several haemostatic 2 parameters compared to the findings from the assay at 37°C (Figure 1 ). Differences were not 3 limited to finish results, but also showed altered baseline values when synchronizing for 4 baseline CBT. Athletes with a finish CBT ≥40.0°C demonstrated a significantly larger fibrin 5 lysis time compared to peers with a lower finish CBT who demonstrated a reduced fibrin lysis 6 time. These findings were confirmed by the analysis in which we varied the assay temperature 7 (Supplemental Table 3 ) and suggest a direct impact of CBT on exercise-induced haemostatic 8 responses. Interestingly, we have observed this effect after analysis of frozen plasma samples 9 which had already been exposed once in vivo to an elevated temperature during the exercise 10 bout. The fact that we were able to identify additional significant changes or stronger baseline-11 to-finish changes compared to when the assays were performed routinely at 37°C suggests 12 that at least part of the observed procoagulant effects are temperature-dependent. Evidence 13 from previous studies in hypothermic patients support our observations. These studies 14
showed that lowering the haemostatic assay temperature to mimic the real-life CBT resulted 15 in a prolonged initiation of blood clotting, whilst the absolute concentration of clotting factors 16 remained unchanged 15 28 29 . Altogether, these data suggest that altering the CBT causes the 17 enzymatic coagulation reaction to become slower at lower temperatures versus faster at 18 higher temperatures 29 . Our findings therefore demonstrate that it is essential to adjust the 19 assay temperature to approximate the subject's CBT in order to obtain the most accurate 20
results. This may not only apply to exercise-induced CBT rises, but also to other conditions 21 where CBT is outside of the normal physiological range. 22 
23
We found that running a 15 km road race resulted in a pro-coagulant state, which is partially 24 dependent on the magnitude of the exercise-induced rise in CBT. None of our subjects 25 experienced clinical coagulation-related problems, which indicates that changes in 26 haemostatic parameters that are accompanied by a CBT up to 41.2°C are of minor clinical 27 relevance. Hence, our data suggest that heatstroke-induced disseminated intravascular 28 coagulation, which is a serious threat for endurance athletes 30 , occurs when CBT passes a 1 certain threshold value. Once an athlete exceeds this threshold and is diagnosed with 2 heatstroke, our data underline the importance of rapid and aggressive cooling, which may 3 reduce the CBT related stimulation of the coagulation cascade and could result in a better 4 outcome. Notably, given the diverse range of peak core body temperatures that individuals 5 develop during exercise 7 , this CBT threshold might be individually determined. 6 7 A potential limitation of the present study is that blood samples were collected within 5 minutes 8 after finishing, while CBT was assessed directly at the finish line. Due to the time difference, 9 subjects may have had a slightly lower CBT at the time of blood collection due to passive 10 cooling. Nevertheless, it is unlikely that these minor CBT differences would impacted our 11 haemostasis results, apart from the fact that it would even underestimate our findings. Another 12 potential limitation of the present study is that we did not correct for exercise-induced changes 13 in plasma volume. However, 82% of our study population was well hydrated, making it unlikely 14 that shifts in plasma volume had a large impact on study outcomes. Importantly, all 15 measurements for the temperature adjusted assays were performed on the same plasma 16 samples and the only manipulated factor was assay temperature. Therefore, the adjusted 17 assay temperature data were not affected by plasma volume changes. Lastly, whilst the 18 applied haemostasis assay has a low inter-assay variability for analyses performed on a single 19 say, the variability is slightly larger when comparing analyses performed on separate days (for 20 example 
Conclusion
1
In conclusion, this study demonstrates that exercise induces a procoagulant state, and our 2 results suggest that this might partially be dependent on the magnitude of the exercise-3 induced CBT rise. Moreover, athletes with a finish CBT as high as 41.2°C do not necessarily 4 demonstrate haemostatic activation leading to clinical symptoms. We therefore hypothesize 5 that prolonged exposure to, or a specific CBT threshold needs to be exceeded before 6 derailment of the haemostatic balance occurs. Most importantly, our results show that 7 adjusting the assay temperature to approximate the subject's CBT is highly recommended to 8 obtain more accurate insight in the haemostatic balance when CBT lies outside the 9 physiological range. 10
11
Practical implications
12
• 15-km running exercise resulted in a significant increase of core body temperature to 
